Literature DB >> 2512578

Tumor suppression involves down-regulation of interleukin 3 expression in hybrids between autocrine mastocytoma and interleukin 3-dependent parental mast cells.

I D Diamantis1, A P Nair, H H Hirsch, C Moroni.   

Abstract

Interleukin 3 (IL-3)-dependent PB-3c mouse mastocytes can be transformed by the v-Ha-ras oncogene to generate autocrine IL-3-producing mastocytomas. Hybrid cell lines were constructed by fusing an IL-3-producing mastocytoma cell line with its IL-3-dependent normal parental cell. Unlike the mastocytoma parent cell line, hybrid cell lines required growth factor for in vitro proliferation, indicating that the IL-3-dependent phenotype is dominant. IL-3 mRNA, expressed at high levels in the tumor cells, appeared down-regulated in the cell hybrids. In contrast, p21v-Ha-ras levels were not reduced in the hybrids. The hybrid lines generated tumors in vivo with drastically prolonged latency times when compared to the tumor parent (10 versus 2 weeks). We propose that down-regulation of IL-3 mRNA production after cell fusion is responsible for the loss of growth autonomy in the hybrids and is likely to play a role in the partial suppression of tumor formation in vivo. Our data are consistent with the hypothesis that a tumor suppressor, present in PB-3c cells, acts as a negative regulator of IL-3 expression.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2512578      PMCID: PMC298482          DOI: 10.1073/pnas.86.23.9299

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  31 in total

1.  Suppression of tumorigenicity in hybrids of normal and oncogene-transformed CHEF cells.

Authors:  R W Craig; R Sager
Journal:  Proc Natl Acad Sci U S A       Date:  1985-04       Impact factor: 11.205

2.  Nucleotide sequence of the p21 transforming protein of Harvey murine sarcoma virus.

Authors:  R Dhar; R W Ellis; T Y Shih; S Oroszlan; B Shapiro; J Maizel; D Lowy; E Scolnick
Journal:  Science       Date:  1982-09-03       Impact factor: 47.728

3.  Growth-factor-independent proliferation in vitro and tumorigenicity in vivo are associated in basophil/mast-cell lines and their somatic hybrids.

Authors:  J F Conscience; F Fischer
Journal:  Differentiation       Date:  1985       Impact factor: 3.880

4.  Spontaneous, in vitro, malignant transformation of a basophil/mast cell line.

Authors:  P E Ball; M C Conroy; C H Heusser; J M Davis; J F Conscience
Journal:  Differentiation       Date:  1983       Impact factor: 3.880

5.  Biologic properties of interleukin 3. II. Serologic comparison of 20-alpha-SDH-inducing activity, colony-stimulating activity, and WEHI-3 growth factor activity by using an antiserum against IL 3.

Authors:  T L Bowlin; A N Scott; J N Ihle
Journal:  J Immunol       Date:  1984-10       Impact factor: 5.422

6.  Monoclonal antibodies to the p21 products of the transforming gene of Harvey murine sarcoma virus and of the cellular ras gene family.

Authors:  M E Furth; L J Davis; B Fleurdelys; E M Scolnick
Journal:  J Virol       Date:  1982-07       Impact factor: 5.103

7.  Autocrine growth induced by src-related oncogenes in transformed chicken myeloid cells.

Authors:  B Adkins; A Leutz; T Graf
Journal:  Cell       Date:  1984-12       Impact factor: 41.582

8.  Flat revertants isolated from Kirsten sarcoma virus-transformed cells are resistant to the action of specific oncogenes.

Authors:  M Noda; Z Selinger; E M Scolnick; R H Bassin
Journal:  Proc Natl Acad Sci U S A       Date:  1983-09       Impact factor: 11.205

9.  Identification of a single chromosome in the normal human genome essential for suppression of hamster cell transformation.

Authors:  A Stoler; N Bouck
Journal:  Proc Natl Acad Sci U S A       Date:  1985-01       Impact factor: 11.205

10.  Genetic origin of mutations predisposing to retinoblastoma.

Authors:  W K Cavenee; M F Hansen; M Nordenskjold; E Kock; I Maumenee; J A Squire; R A Phillips; B L Gallie
Journal:  Science       Date:  1985-04-26       Impact factor: 47.728

View more
  6 in total

1.  Somatic mRNA turnover mutants implicate tristetraprolin in the interleukin-3 mRNA degradation pathway.

Authors:  G Stoecklin; X F Ming; R Looser; C Moroni
Journal:  Mol Cell Biol       Date:  2000-06       Impact factor: 4.272

2.  Rapamycin destabilizes interleukin-3 mRNA in autocrine tumor cells by a mechanism requiring an intact 3' untranslated region.

Authors:  R Banholzer; A P Nair; H H Hirsch; X F Ming; C Moroni
Journal:  Mol Cell Biol       Date:  1997-06       Impact factor: 4.272

3.  Cyclosporin A promotes translational silencing of autocrine interleukin-3 via ribosome-associated deadenylation.

Authors:  A P Nair; H H Hirsch; M Colombi; C Moroni
Journal:  Mol Cell Biol       Date:  1999-01       Impact factor: 4.272

4.  c-jun N-terminal kinase is involved in AUUUA-mediated interleukin-3 mRNA turnover in mast cells.

Authors:  X F Ming; M Kaiser; C Moroni
Journal:  EMBO J       Date:  1998-10-15       Impact factor: 11.598

5.  Suppressible and nonsuppressible autocrine mast cell tumors are distinguished by insertion of an endogenous retroviral element (IAP) into the interleukin 3 gene.

Authors:  H H Hirsch; A P Nair; C Moroni
Journal:  J Exp Med       Date:  1993-08-01       Impact factor: 14.307

6.  Differential analysis of biological networks.

Authors:  Da Ruan; Alastair Young; Giovanni Montana
Journal:  BMC Bioinformatics       Date:  2015-10-09       Impact factor: 3.169

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.